Search results
Age-Related Macular Degeneration: Putting a Hole in Our World
WebMD· 6 days agoWhen we’re young, we take our macula for granted. At the center of our retina – the deepest layer of the eye that’s chock-full of photoreceptors and that confers color to our world – the macula ...
Short Interest in Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Rises By 6.2%
ETF DAILY NEWS· 5 hours agoAdverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) was the target of a large increase in short interest during the month of April. As of April 30th, there was short interest totalling ...
EyePoint Pharmaceuticals Q1 2024 Earnings: Revenue Surpasses Estimates Despite Challenges
GuruFocus.com via Yahoo Finance· 6 days agoThe company utilizes its proprietary Durasert E and Verisome technology platforms to develop...
The most innovative Mother’s Day campaigns from Dove, MoneyGram, DoorDash & more
The Drum· 6 days agoFrom heartwarming reunions facilitated by DoorDash to MullenLowe planting career opportunities for...
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
TipRanks via Yahoo Finance· 7 days agoRisk and reward are the yin and yang of stock trading, the two essential yet opposing forces in...
Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look
Guru Focus· 6 days agoOn May 9, 2024, Adverum Biotechnologies Inc (ADVM, Financial), a trailblazer in gene therapy for ocular diseases, disclosed its financial outcomes for the first quarter of 2024 through its 8 ...
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer...
The Record Gazette· 2 days agoKodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases ...
Clearside Biomedical stock target cut, maintains Buy rating By Investing.com
Investing.com· 3 days agoOn Monday, Clearside Biomedical (NASDAQ:CLSD) saw its price target adjusted by H.C. Wainwright. The...
Why your eye colour might be wrong and 9 other bizarre facts about your peepers
The US Sun· 5 days agoCHANCES are you only really focus on your eyes when there’s something wrong - think nasty infection...
Qsemble Capital Management LP Purchases Shares of 239 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 2 days agoQsemble Capital Management LP acquired a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the 4th quarter, according to its most recent 13F filing ...